Sean Sciara announced on LinkedIn that he has taken on the position of chief commercial officer at Onward Medical.

The global pacemakers market is on track to witness steady growth, projected at a rate of 3-4% annually by 2028. This expansion is fueled by a confluence of factors, from the growing burden of ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A ...

Boston Scientific Atrial Solutions Chief Medical Officer Dr. Brad Sutton also offered advice for medtech designers and ...

Fintel reports that on October 22, 2025, BTIG reiterated coverage of Boston Scientific (NYSE:BSX) with a Buy recommendation. Analyst Price Forecast Suggests 21.55% Upside As of September 30, 2025, the ...

Boston Scientific raised its annual profit forecast on Wednesday, after beating third-quarter profit estimates on strong ...

For the current quarter ending in December, Boston Scientific expects its per-share earnings to range from 77 cents to 79 cents. The company expects full-year earnings in the range of $3.02 to $3.04 ...

Imagine asking a search engine platform questions about your health and getting responses based on your own DNA. That's exactly what the founders of Bystro have created.

Oct 15 (Reuters) - Core Scientific's (CORZ.O), opens new tab board urged its shareholders on Wednesday to vote for the crypto miner's proposed sale to CoreWeave (CRWV.O), opens new tab as the company ...